Where nuclear cardiology moves forward.
A day of clinical insight, live case discussion and cross-disciplinary connection for everyone shaping the future of cardiac imaging.
Conference Overview
Nuclear cardiac imaging is changing faster than at any point in the last decade — new indications, new tracers and new evidence are reshaping how we diagnose and manage cardiac disease.
The BNCS Annual Conference 2026 brings the whole nuclear cardiology community together for a day of the latest science, live case discussion, and the kind of cross-disciplinary conversation that only happens face to face.
This conference is for: Cardiologists · Nuclear Radiologists · Nuclear Medicine Technologists · Nuclear Medicine Physicists · Nurses · Trainees
Whether you're here to sharpen your reporting, explore a new subspecialty, or build the connections that shape your career, this is where the field's next steps get made.
Programme Highlights
A full day, four sessions, and a line-up spanning the leading edge of nuclear cardiology.
State-of-the-Art Nuclear Imaging — opening the day with PET myocardial perfusion, quantitative SPECT, and total-body PET, chaired by Prof. Richard Underwood and Prof. Rick Steeds.
Nuclear Imaging in Amyloidosis — bone tracer imaging and novel tracer developments, followed by an industry-sponsored symposium on first-line treatment of ATTR cardiac amyloidosis with Prof. Julian Gillmore.
AGM, Best Case Presentation & the Young Investigator Award — the Society's annual business, followed by the best case presentation submissions and this year's Young Investigator Award presentations.
Infection and Inflammation — closing the day with imaging in myocarditis, cardiac sarcoidosis, and device-related infective endocarditis.
Registration Fees
- Consultants: £50
- Trainees: £25
- AHPs, Physicists and Technologists: £25
This nominal fee includes annual membership of BNCS.
Course Directors
Dr William Moody
Dr Paul Scully
Dr Imran Sunderji
Dr Matthew Balerdi
Supported by
This conference has been supported by Alnylam UK, Bayer, Pfizer and Bracco.
The scientific programme has not been influenced in any way by its sponsors (with the exclusion of the industry sponsored symposium).
Days to Go
- Days36
- Hours15
- Minutes51
- Seconds48
Wellcome Collection
You May Also Be Interested In...
Emerging Technologies in Nuclear Medicine
04/11/2026 | 09:00-17:00 | TheStudio, Birmingham
Explore the latest emerging technologies in Nuclear Medicine, with expert insights into innovative imaging, therapies and future developments, supporting best practice and professional growth.
Emerging Technologies in Nuclear Medicine will showcase the latest advances in imaging, AI and novel therapies shaping the future of the field. Join professionals from across Nuclear Medicine to explore innovation, share knowledge and gain insight into developments influencing clinical practice.
